Minimally Invasive Surgery Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

In minimally invasive surgery, doctors use different operating procedures with less destruction to the body than with open surgery. In general, minimally invasive surgery is linked with less pain, fewer complications, and a shorter hospital stay. One of the types of minimally invasive surgery is robotic surgery. It delivers a magnified, 3D view of the surgical site and helps the surgeon control with accuracy, control, and flexibility. Continual inventions in minimally invasive surgery make it beneficial for people with a wide spread of conditions.

The “Global Minimally Invasive Surgery Market Analysis to 2031” is a specialized and in-depth study of the medical devices industry with a special focus on global market trend analysis. The report aims to provide an overview of the minimally invasive surgery market with detailed market segmentation by product, type of surgery, end-user, and geography. The report provides key statistics on the market status of the leading minimally invasive surgery market players and offers key trends and opportunities in the market.

MARKET DRIVERS

Factors driving the minimally invasive surgery market growth are improvements of minimally invasive surgery over open surgical procedures, improving the prevalence of lifestyle-related and chronic disorders, and the accessibility of innovative minimally invasive surgery devices. However, the need for more expert specialists and modifying the regulatory landscape in the medical device industry are the factors restraining the minimally invasive surgery market growth.

The accessibility of innovative minimally invasive surgery devices is raising the market growth, according to the National Library of Medicine, introducing new technologies or techniques starts a change in how things are done. Since the beginning of the 1980s, however, there have been continuous innovations to improve MIS, and its concepts are staying the same. Technological innovations in surgical instruments, e.g., instrument and suture or MIS-associated technology such as robotic visual guidance systems for Lasixoscopic Single Incisioning surgery, are also part of this category. The accessibility of innovative minimally invasive surgery devices has revolutionized surgical procedures by offering several advantages over traditional open surgeries, including smaller incisions, reduced trauma to the patient, faster recovery times, and lower post-operative complications. This increased accessibility of these devices has contributed to the widespread adoption of minimally invasive techniques across various surgical specialties. Thus, the accessibility of innovative minimally invasive surgery devices fueling the growth of the minimally invasive surgery market.

GLOBAL SEGMENTAL ANALYSIS

The global minimally invasive surgery market is segmented based on product into handheld instruments, inflation devices, surgical scopes, cutting instruments, guiding devices, electrosurgical & electrocautery instruments, and other instruments. Further, handheld instruments are segmented as graspers, retractors/elevators, suturing instruments, dilators, and other handheld instruments. Further, inflation devices are segmented as balloons and balloons inflation devices. Further, surgical scopes are segmented as laparoscopes, urology endoscopes, arthroscopes, neuroendoscopes, and other surgical scopes. Further, cutting instruments are segmented as trocars and other cutting instruments. Further, guiding devices are segmented as guiding catheters and guidewires. Further, electrosurgical & electrocautery Instruments are segmented as electrosurgical instruments and electrocautery devices. Based on type of surgery, the market is segmented into cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, cosmetic & bariatric surgery, urological surgery, and other surgeries. The market is segmented into hospitals, specialty clinics, and ambulatory surgery centers based on end-user.

Based on the type of surgery, the orthopedic surgery segment dominated the global minimally invasive surgery market share. The orthopedic application segment dominated the market, with a revenue share exceeding 23.6% in 2021. In orthopedic MIS procedures, no muscles need to be cut or separated from the bone. Consequently, patients' satisfaction has improved, and the healing process is more rapid with this approach. In the case of hip or knee substitute surgery, MIS is most used. Surgical procedures which minimize the time to operate, as well as post-operative complications and shorten hospital stays, are sought by hospitals and surgeons. On the other hand, pats are looking for surgical procedures that reduce trauma and speed up recovery. Thus, the orthopedic surgery segment drives the minimally invasive surgery market growth.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides minimally invasive surgery market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South & central America. The minimally invasive surgery market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The minimally invasive surgery market report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The minimally invasive surgery market report also provides an exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the minimally invasive surgery market in these regions.

In 2021, North America accounted for a revenue share of 44,8 % in the Regional MS market owing to an excessive incidence of accidental injury and a growing elderly population. The Organization for Economic Co-operation and Development (OECD) report found that per capita health expenditure in the United States is significantly higher than all other countries of the world. Moreover, patients in the U.S. are allowed to choose treatment methods as well as health care providers. In North America, it is likely to have a favorable impact on the managed information systems market. In contrast, from 2022 to 2031, Asia Pacific is anticipated to grow at the highest pace of all regional markets.

MARKET PLAYERS

The report covers key developments in the minimally invasive surgery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved the way for the expansion of business and the customer base of market players. The market payers from the Minimally Invasive Surgery market are anticipated to have lucrative growth opportunities in the future with the rising demand for minimally invasive surgery in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the minimally invasive surgery market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

• Abbott Laboratories
• B.Braun Melsungen
• AG, Becton, Dickinson and Company
• Boston Scientific Corporation
• CONMED Corporation
• Johnson&Johnson Services, Inc.
• Medtronic plc,
• Smith&Nephew plc,
• Stryker Corporation
• Zimmer Biomet

Recent Developments

• In May 2023, Stryker Corporation announced today that surgeons began early product surveillance cases for its Q Guidance system with cranial guidance software. This technology provides surgeons with image planning and an intraoperative guidance system to support cranial surgery. Its uses include intraoperative guidance, where a reference to a rigid anatomical structure can be identified. The system tracks navigation tools in inpatient imaging and displays their position and orientation.
• In Oct 2022, Medtronic plc a global healthcare technology leader, has announced three significant global market-entrance and indication expansion approvals for its Hugo robotic-assisted surgery (RAS) system.
• In April 2021, Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal health and one of America's most respected healthcare providers, announced The FDA 510k clearance of the ROSA Partial Knee System for robotic-assisted partial knee replacement surgery. The ROSA Partial Knee System is the newest addition to ROSA Robotics, Zimmer Biomet's multiple-application robotics platform, which includes the ROSA Knee System for total knee replacement surgery and ROSA ONE for neurosurgical and spine procedures.

The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Minimally Invasive Surgery Report Scope